Have a personal or library account? Click to login
Age-dependent myocardial transcriptomic changes in the rat. Novel insights into atrial and ventricular arrhythmias pathogenesis Cover

Age-dependent myocardial transcriptomic changes in the rat. Novel insights into atrial and ventricular arrhythmias pathogenesis

Open Access
|Mar 2014

References

  1. 1. Chow GV, Marine JE, Fleg JL. Epidemiology of arrhythmias and conduction disorders in older adults. Clin Geriatr Med. 2012 Nov;28(4):539-53. DOI: 10.1016/j. cger.2012.07.003
  2. 2. Mirza M, Strunets A, Shen WK, Jahangir A. Mechanisms of arrhythmias and conduction disorders in older adults. Clin Geriatr Med. 2012 Nov;28(4):555-73. DOI: 10.1016/j.cger.2012.08.00510.1016/j.cger.2012.08.005
  3. 3. Brembilla-Perrot B. Age-related changes in arrhythmias and electrophysiologic properties. Card Electrophysiol Rev. 2003 Jan;7(1):88-91. DOI: 10.1023/A:102361172794710.1023/A:1023611727947
  4. 4. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science. 1996 Jul;273:59-63. DOI: 10.1126/science.273.5271.5910.1126/science.273.5271.59
  5. 5. Ramsey JJ, Harper ME, Weindruch R. Restriction of energy intake, energy expenditure, and aging. Free Radic Biol Med. 2000 Nov;29:946-68. DOI: 10.1016/ S0891-5849(00)00417-210.1016/S0891-5849(00)00417-2
  6. 6. Golden TR, Hinerfeld DA, Melov S. Oxidative stress and aging: beyond correlation. Aging Cell. 2002 Dec;1:117-23. DOI: 10.1046/j.1474-9728.2002.00015.x10.1046/j.1474-9728.2002.00015.x
  7. 7. Gavrilov LA, Gavrilova NS. Evolutionary theories of aging and longevity. Sci World J. 2002 Feb;2:339-56. DOI: 10.1100/tsw.2002.9610.1100/tsw.2002.96
  8. 8. Volkova M, Garg R, Dick S, Boheler KR. Aging-associated changes in cardiac gene expression. Cardiovasc Res. 2005 May;66(2):194-204. DOI: 10.1016/j.cardiores. 2004.11.016
  9. 9. Gaborit N, Wichter T, Varro A, Szuts V, Lamirault G, Eckardt L, et al. Transcriptional profiling of ion channel genes in Brugada syndrome and other right ventricular arrhythmogenic diseases. Eur Heart J. 2009 Feb;30(4):487-96. DOI: 10.1093/eurheartj/ehn52010.1093/eurheartj/ehn520
  10. 10. Boheler KR, Volkova M, Morrell C, Garg R, Zhu Y, Margulies K, et al. Sex- and age-dependent human transcriptome variability: Implications for chronic heart failure. Proc Natl Acad Sci U S A. 2003 Mar; 100(5):2754-9. DOI: 10.1073/pnas.043656410010.1073/pnas.0436564100
  11. 11. Melov S, Coskun PE, Wallace DC. Mouse models of mitochondrial disease, oxidative stress, and senescence. Mutat Res. 1999 Jul;434: 233-42. DOI: 10.1016/ S0921-8777(99)00031-210.1016/S0921-8777(99)00031-2
  12. 12. Liang H, Masoro EJ, Nelson JF, Strong R, McMahan CA, Richardson A. Genetic mouse models of extended lifespan. Exp Gerontol. 2003 Nov-Dec;38:1353-64. DOI: 10.1016/j.exger.2003.10.01910.1016/j.exger.2003.10.01914698816
  13. 13. Jazwinski SM. Aging and longevity genes. Acta Biochim Pol. 2000;47:269-79.10.18388/abp.2000_4007
  14. 14. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2011 Mar;123:e269-36713. DOI: 10.1161/ CIR.0b013e318214876d10.1161/CIR.0b013e318214876d21382897
  15. 15. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ,Berry JD,Borden WB, et al. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012 Jan;125(1):188-97. DOI: 10.1161/ CIR.0b013e3182456d46
  16. 16. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006 Jul;114:119-25. DOI: 10.1161/CIRCULATIONAHA.105.59514010.1161/CIRCULATIONAHA.105.59514016818816
  17. 17. Mozaffarian D, Furberg CD, Psaty BM, Siscovick D. Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation. 2008 Aug;118:800-7. DOI: 10.1161/CIRCULATIONAHA. 108.785626
  18. 18. Wakili R, Voigt N, Kääb S, Dobrev D, Nattel S. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest. 2011 Aug;121(8):2955-68. DOI: 10.1172/JCI4631510.1172/JCI46315314873921804195
  19. 19. Nattel S, Li D, Yue L. Basic mechanisms of atrial fibrillation: very new insights into very old ideas. Annu Rev Physiol. 2000;62:51-77. DOI: 10.1146/annurev.physiol. 62.1.51
  20. 20. Yamada M, Ohta K, Niwa A, Tsujino N, Nakada T, Hirose M. Contribution of L-type Ca2+ channels to early afterdepolarizations induced by I Kr and I Ks channel suppression in guinea pig ventricular myocytes. J Membr Biol. 2008 Apr;222(3):151-66. DOI: 10.1007/ s00232-008-9113-910.1007/s00232-008-9113-918566732
  21. 21. Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM. Atrial L-Type Ca2+ currents and human atrial fibrillation. Circ Res. 1999 Sep;85:428-36. DOI: 10.1161/01.RES.85.5.42810.1161/01.RES.85.5.42810473672
  22. 22. Gaspo R, Bosch RF, Bou-Abboud E, Nattel S. Tachycardia- induced changes in Na+ current in a chronic dog model of atrial fibrillation. Circ Res. 1997 Dec;81:1045-52. DOI: 10.1161/01.RES.81.6.104510.1161/01.RES.81.6.10459400386
  23. 23. Makiyama T, Akao M, Shizuta S, Doi T, Nishiyama K, Oka Y, et al. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol. 2008 Oct;52(16):1326-34. DOI: 10.1016/j.jacc.2008.07.01310.1016/j.jacc.2008.07.01318929244
  24. 24. Olesen MS, Refsgaard L, Holst AG, Larsen AP, Grubb S, Haunsø S, et al. A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation. Cardiovasc Res. 2013 Jun;98(3):488-95. DOI: 10.1093/cvr/cvt02810.1093/cvr/cvt02823400760
  25. 25. Olson TM, Alekseev AE, Moreau C, Liu XK, Zingman LV, Miki T, et al. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation. Nat Clin Pract Cardiovasc Med. 2007 Feb;4(2):110-6. DOI: 10.1038/ncpcardio079210.1038/ncpcardio0792201330617245405
  26. 26. Limberg SH, Netter MF, Rolfes C, Rinné S, Schlichthörl G, Zuzarte M, et al. TASK-1 channels may modulate action potential duration of human atrial cardiomyocytes. Cell Physiol Biochem. 2011;28(4):613-24. DOI: 10.1159/00033575710.1159/000335757370918322178873
  27. 27. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997 Aug;96(4):1180-4. DOI: 10.1161/01.CIR.96.4.118010.1161/01.CIR.96.4.11809286947
  28. 28. Scridon A, Gallet C, Arisha MM, Oréa V, Chapuis B, Li N, et al. Unprovoked atrial tachyarrhythmias in aging spontaneously hypertensive rats: The role of the autonomic nervous system. Am J Physiol Heart Circ Physiol. 2012 Aug;303(3):H386-92. DOI: 10.1152/ ajpheart.00004.201210.1152/ajpheart.00004.201222661510
  29. 29. Lai LP, Su MJ, Lin JL, Tsai CH, Lin FY, Chen YS, et al. Measurement of funny current (I(f)) channel mRNA in human atrial tissue: Correlation with left atrial filling pressure and atrial fibrillation. J Cardiovasc Electrophysiol. 1999 Jul;10:947-53. DOI: 10.1111/j.1540-8167.1999.tb01265.x10.1111/j.1540-8167.1999.tb01265.x10413374
  30. 30. Morel E,Meyronet D, Thivolet-Bejuy F, Chevalier P. Identification and distribution of interstitial Cajal cells in human pulmonary veins. Heart Rhythm. 2008 Jul;5:1063-7. DOI: 10.1016/j.hrthm.2008.03.05710.1016/j.hrthm.2008.03.05718598966
  31. 31. Suenari K, Cheng CC, Chen YC, Lin YK, Nakano Y, Kihara Y, et al. Effects of Ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis. J Cardiovasc Electrophysiol. 2012 Feb;23(2):200-6. DOI: 10.1111/j.1540-8167.2011.02173.x10.1111/j.1540-8167.2011.02173.x21914029
  32. 32. Li Y, Huang Y, Li Z, Wang H, Song J, Liu Y, et al. Effect of ivabradine on hyperpolarization activated cation current in canine pulmonary vein sleeve cardiomyocytes with atrial fibrillation J Geriatr Cardiol. 2008;5(1):39-42.
  33. 33. Xue X, Yan GX. The funny current (If): is it a novel antiarrhythmic target to treat atrial fibrillation? J Cardiovasc Electrophysiol. 2012 Feb;23(2):207-8. DOI: 10.1111/j.1540-8167.2011.02209.x 10.1111/j.1540-8167.2011.02209.x22050077
DOI: https://doi.org/10.2478/rrlm-2014-0001 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 9 - 23
Published on: Mar 25, 2014
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2014 Alina Scridon, Emmanuelle Fouilloux-Meugnier, Emmanuelle Loizon, Marcel Perian, Sophie Rome, Claude Julien, Christian Barrès, Philippe Chevalier, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons License.